Want to join the conversation?
Medical device company $MDT said that it enrolled the first patients for the CoreValve Evolut R System, the recapturable, self-expanding transcatheter aortic valve replacement (TAVR) system in the US. A clinical trial will be held enrolling low-risk patients with 1:1 randomization to receive the Evolut R System or undergo open-heart surgery.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.